Sepsis Leadership FloPatch has earned recognition in sepsis care through awards and a growing body of peer-reviewed evidence supporting personalized fluid resuscitation at the bedside. This credibility can be leveraged to engage sepsis programs, ICU teams, and clinical researchers for pilots, case studies, and enrollment in trials across hospital networks seeking advanced hemodynamic monitoring.

Growth Financing Financial backing from RBCx signals a growth runway to scale deployments, expand the field force, and pursue larger enterprise pilots with health systems that require compelling return on investment from real-time hemodynamic monitoring.

Market Expansion FloPatch’s inside‑and‑outside hospital capability creates a broad sales opportunity across acute care, post-acute, remote monitoring, and transport workflows. The company’s Canadian roots with offices in Sudbury and Toronto provide a regional entry point and potential channels through hospital distributors and group purchasing organizations.

IT and Data The use of Google Cloud Platform and Salesforce indicates readiness for enterprise integration with EMR systems, data analytics, and clinician dashboards. This enables sales motion focused on IT and procurement stakeholders, highlighting interoperability, data portability, and measurable outcomes.

Clinical Credibility Strong clinical validation and sepsis leadership positioning make FloPatch a favorable option for procurement teams, payer discussions, and research networks aiming to improve sepsis outcomes with real time hemodynamic monitoring and tailored fluid management.